Medical Press Release - Page 2 of 12 - Medika Life : Keeping you informed

If validated, the discovery by St Jude scientists could offer real tools to deal with hyperinflammatory immune responses, one of the leading causes of death in Covid-19 infections

Zero-Contact Medical Station for Safe and Rapid PCR Covid-19 Testing

Medika Life - May 6, 2021

Zero Contact Rapid PCR Testing. The biggest risk of infection for medical staff is during intubation, nasal swabbing, and personal protective equipment (PPE) removal

Uqora Develops the First Non-Antibiotic Treatment Option for UTIs

Medika Life - September 29, 2020

The new drug program aims to decrease the amount of UTIs that would otherwise require antibiotic intervention.

Treatment for Schizophrenia and Bipolar I Disorder Gets Vote of Support

Medika Life - October 10, 2020

The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

LATEST

TRENDING

Medika’s Call for Food Aid for Starving Filipino Children

Lover, the App That Helps Women Reach Orgasm

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

The 50 Most Influential Leaders in Pharmacy 2022 Awards

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

Children with no COVID-19 symptoms may shed virus for weeks

South University Announces New MSPA Program at West Palm Beach Campus

EDITORS CHOICE

St. Jude scientists identify possible COVID-19 treatment in the lab

Zero-Contact Medical Station for Safe and Rapid PCR Covid-19 Testing

Uqora Develops the First Non-Antibiotic Treatment Option for UTIs

Treatment for Schizophrenia and Bipolar I Disorder Gets Vote of Support

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories